This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 May;73(9):1093; author reply 1093-4.

doi: 10.1038/ki.2008.46.

Lack of mortality benefit with sevelamer

C R Nolan, D A McCarron

PMID: 18414441
DOI: 10.1038/ki.2008.46

Free article

Comment

Lack of mortality benefit with sevelamer

C R Nolan et al. Kidney Int. 2008 May.

Free article

. 2008 May;73(9):1093; author reply 1093-4.

doi: 10.1038/ki.2008.46.

Authors

C R Nolan, D A McCarron

PMID: 18414441
DOI: 10.1038/ki.2008.46

No abstract available

PubMed Disclaimer

Comment on

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK. Suki WN, et al. Kidney Int. 2007 Nov;72(9):1130-7. doi: 10.1038/sj.ki.5002466. Epub 2007 Aug 29. Kidney Int. 2007. PMID: 17728707 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information